TENSION FREE VAGINAL TAPE UNKNOWN PRODUCT
Report
- Report Number
- 2210968-2019-78123
- Event Type
- Injury
- Date Received
- January 2, 2019
- Report Date
- December 13, 2018
- Manufacturer
- ETHICON INC.
- Product Code
- OTN
- PMA / PMN Number
- K974098
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FI
- Reporter Occupation
- OTHER
Narratives
(B)(4). THIS REPORT IS RELATED TO A JOURNAL ARTICLE, THEREFORE NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE BATCH HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. CITATION: INT UROGYNECOL J (2015) 26:57¿63; DOI 10.1007/S00192-014-2454-2.
IT WAS REPORTED VIA JOURNAL ARTICLE: "TITLE: TVT VERSUS LAPAROSCOPIC MESH COLPOSUSPENSION: 5-YEAR FOLLOW-UP RESULTS OF A RANDOMIZED CLINICAL TRIAL". AUTHOR(S): A. VALPAS & S. ALA-NISSILÄ & E. TOMAS & C. G. NILSSON. CITATION: INT UROGYNECOL J (2015) 26:57¿63; DOI 10.1007/S00192-014-2454-2. THE AIM OF THE PRESENT TRIAL WAS TO COMPARE THE NEW MINIMALLY INVASIVE TENSION-FREE VAGINAL TAPE (TVT) PROCEDURE WITH LAPAROSCOPIC MESH COLPOSUSPENSION (LCM). IN A 5-YEAR FOLLOW UP BETWEEN NOV1999 AND AUG2001, 121 FEMALE PATIENTS WITH HISTORY OF STRESS URINARY INCONTINENCE (SUI) UNDERWENT TVT PROCEDURES (N=70; MEAN AGE OF 50 YEARS [RANGE 33-67 YEARS]) AND LCM PROCEDURES (N=51; MEAN OF 48 YEARS [29-68 YEARS]). IN TVT GROUP, TVT KIT, GYNECARE WAS USED. POSTOPERATIVELY IN TVT GROUP, COMPLICATIONS INCLUDED PROTRUSION OF TVT SLING IN THE MIDLINE (N=1) FOR WHICH THE VISIBLE PART WAS EXCISED; PROLAPSE (N=1) FOR WHICH PROLAPSE PROCEDURE WAS PERFORMED; AND PERSISTENT INCONTINENCE (N=1) TREATED WITH BULKING AGENT INJECTION WITH ZUIDEX.. THE RESULTS SUGGEST THAT THE TVT PROCEDURE IS SUPERIOR TO THE LCM EVALUATED BOTH BY THE PER PROTOCOL AND THE INTENTION-TO-TREAT PRINCIPLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 3140 | TENSION FREE VAGINAL TAPE UNKNOWN PRODUCT | MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGICAL | OTN | ETHICON INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |